email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2641-1725

LOJ Medical Sciences

Mini Review(ISSN: 2641-1725)

Neuroleptic Cardiomyopathy: Let’s Get Acquainted

Volume 1 - Issue 4

Volkov VP*

  • Author Information Open or Close
    • Tver center of judicial examinations, Russia

    *Corresponding author:Volkov VP, Tver center of judicial examinations, Russia, 170008, Tver A Zavidov St., 24, of. 6

Received: September 05, 2018;   Published: September 11, 2018

DOI: 10.32474/LOJMS.2018.01.000117

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

The presented mini-review summarizes the results of our own research and rather rare literature data on the problem of neuroleptic cardiomyopathy. The aspects of etiology, epidemiology, clinical course, electrocardiographic signs and pathomorphology of the disease are briefly considered. The question of nosological independence of neuroleptic cardiomyopathy is raised. Neuroleptic (antipsychotic) cardiomyopathy (NCMP) is a little known to a wide range of doctors iatrogenic pathology. It is associated with a side cardiotoxic effect of antipsychotic drugs [1-9]. The disease belongs to secondary specific metabolic dilated cardiomyopathies [10-12] and is characterized by diffusion damage of a myocardium, by sharp decrease in its contractile function and by the progressing of congestive chronic heart failure (CHF) [8,10,11,13-17].

Mini Review| Refrences|

https://www.high-endrolex.com/21